Generex Biotechnology Corp. (OTCMKTS:GNBT)’s shares is trading at $0.039. The company on Feb. 27 announced publication of studies examining potential biomarkers associated with overall survival in prostate cancer patients treated with its immunotherapeutic agent AE37. The retrospective study examined data from 29 patients immunized as part of a Phase I study. The immunotherapeutic agent AE37 is being developed by Antigen Express, Inc. (www.antigenexpress.com), a wholly-owned subsidiary of Generex, for multiple cancer indications. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04 in last session, and closed at $0.0390, while the day range of GNBT stock is $0.04-$0.04. The stock showed a negative weekly performance of -2.50%.
Delcath Systems, Inc. (DCTH) reported that it will host a conference call and webcast on 12th March, 2014 at 4:30 p.m. ET to discuss its financial results for the 4th quarter and full year of 2013 ended 31st December, 2013, and provide an update on recent corporate progress. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.31, in last session and closed at $0.306, by gained -1.29%. The 52 week range was $0.22-$2.19.Company’s market capitalization is $38.64 million.
Stock analysts at UBS AG boosted their target price on shares of Valeant Pharmaceuticals Intl (NYSE:VRX) from $141.00 to $170.00 in a report issued on Friday, Analyst Ratings Net reports. The firm currently has a “buy” rating on the stock. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock loosed -0.75% and finished the last session at $145.13. The EPS of the stock remained -3.26.Company’s market capitalization is $48.35 billion.
Alkermes Plc (NASDAQ:ALKS) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Wednesday, AmericanBankingNews.com reports. The firm currently has a $57.00 price target on the stock. Zacks‘s price target points to a potential upside of 19.05% from the company’s current price. Alkermes Plc (NASDAQ:ALKS) stock opened the session at $47.97, and closed the session at $47.36. The 52 week range of the ALKS stock remained $22.17-$54.25 and the day range was $47.35-$48.52.
Leave a Reply